The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Gemcitabine, nab-paclitaxel, cisplatin, and anakinra (AGAP) treatment in patients with localized pancreatic ductal adenocarcinoma (PDAC).

Carlos  Becerra

Honoraria - Taiho Pharmaceutical

Speakers' Bureau - Celgene; Lilly; Taiho Pharmaceutical

Andrew Scott  Paulson

Stock and Other Ownership Interests  - Alexion Pharmaceuticals; Immunomedics; Juno Therapeutics

Consulting or Advisory Role - Advanced Accelerator Applications; Bristol-Myers Squibb; Ipsen; Merrimack; Taiho Pharmaceutical

Research Funding - Ipsen (I); Lilly (I)

Keith M  Cavaness

No Relationships to Disclose

Scott A.  Celinski

No Relationships to Disclose